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SSD: Sterol-Sensing Direct
Cholesterol homeostasis is established by a complex
of three proteins, one of which contains a hydrophobic
domain previously termed a sterol-sensing domain.
New biochemical studies of this domain demonstrate
direct high-affinity binding of the sterol-sensing do-
main to sterol.
In the July 23, 2004, issue of Molecular Cell, Goldstein
and Brown have filled in another important piece of
the picture of sterol metabolism (Radhakrishnan et al.,
2004). The focus of recent work from this lab has been
Figure 1. Cholesterol Binds Directly to SCAP, Inducing Its Retentionthe intricate feedback mechanism that senses sterol, or
in the Endoplasmic Reticulumits absence, and alters transcription of genes such as
(A) SCAP (brown) binds cholesterol (yellow, not drawn to scale) andHMG CoA reductase and the LDL receptor, the activity of
adopts a conformation that binds to INSIG (black), so becomingwhich leads to sterol synthesis and uptake, respectively
anchored in the ER.
(Brown and Goldstein, 1999). Previous work had shown (B) In the absence of cholesterol, SCAP is released from INSIG
that the input to the mechanism is a combination of and enters the exocytic pathway along with SREBP (blue), which is
cleaved in the Golgi to release the transcriptionally active domaincholesterol and also oxysterols, derivatives of choles-
(dark blue) into the cytoplasm (figure adapted from Loewen andterol present at low levels. The mechanism consists of
Levine, 2002).three proteins: (1) the transcription factor itself: sterol
responsive element binding protein (SREBP), an integral
membrane protein of the endoplasmic reticulum (ER) of cholesterol. This view was supported by work show-
ing that binding to INSIG stabilizes the effect of choles-that is activated by cleavage to allow the transcription-
ally active domain to enter the nucleus; (2) SREBP-cleav- terol on SCAP (Adams et al., 2003). However, other data
from expression of mammalian SREBP, SCAP, andage activating protein (SCAP): a binding partner that
mediates activation of SREBP by trafficking it to the INSIG in flies indicated that the mechanism might be
indirect via more general biophysical effects on the ERGolgi, where cleavage occurs; and (3) INSIG: an integral
membrane protein of the ER that anchors SCAP-SREBP membrane, because phosphatidylethanolamine, which
is structurally unrelated to sterols, had a partial effectcomplexes in the ER (Yang et al., 2002).
How might these three proteins respond to changes on SCAP retention (Dobrosotskaya et al., 2003).
In their new paper, Brown, Goldstein, and coworkersin the lipid content of the ER membrane? The most likely
candidate for the lipid-sensitive switch in the SREBP- resolve this issue (Radhakrishnan et al., 2004). Simply
put, they have purified the polytopic region of SCAP toSCAP-INSIG mechanism was SCAP, which shares a re-
gion of sequence homology with several other proteins homogeneity and shown a specific, direct interaction
in vitro with cholesterol (half-maximal binding at 100involved in cholesterol metabolism: HMG CoA reduc-
tase, patched, dispatched, 7-dehyrdocholesterol reduc- nM), which induces retention of SCAP in the ER (Figure
1). Binding was also shown for other compounds knowntase, Neimann Pick type C protein 1 (NPC1), and NPC1-
like 1 (NPC1L1). All these proteins are polytopic; i.e., to enhance the SCAP-INSIG interaction, including the
aromatic neuroleptic drugs trifluoperazine and chlor-they have domains made up of multiple (between 8 and
12) trans-membrane helices (TMHs). The region shared promazine, as well as a limited range of sterols including
the plant lipid sitosterol. This brief description does littlebetween these proteins consists of five TMHs and was
originally described as being essential for the direct justice to the evident difficulties of working with a hy-
drophobic polypeptide binding a hydrophobic ligand inregulation of HMG CoA reductase by cholesterol, hence
called a sterol-sensing domain (SSD) (Roitelman and aqueous solution: just finding the right concentration of
a detergent suitable for both protein and lipid was highlySimoni, 1992).
Investigations of the way in which SCAP might re- complex. The analysis of the peptide-lipid complex in-
cluded size-exclusion chromatography, after which lipidspond to cholesterol started with the isolation of SCAP
mutants that did not respond to sterol, and took a big still coeluted with peptide. As a by-product of this exper-
iment, and verified in others, SCAP was found to formstep forward when a sterol-dependent switch was tenta-
tively identified: a region of SCAP close to the SSD tetramers, the significance of which remains to be estab-
lished.showed an altered pattern of tryptic digestion de-
pending on whether cholesterol was present or not, and Another piece of the jigsaw still not in place is the
role of oxysterols. Highly bioactive compounds such aswas independent of oxysterols (Brown et al., 2002). The
altered digestion was inferred to mean that cholesterol 25-hydroxycholesterol do not interact with SCAP in vitro
(Radhakrishnan et al., 2004) and yet are essential formight bind directly to the SSD and that a conformational
change would ensue, leading to tighter SCAP-INSIG the response to sterol in vivo (Brown and Goldstein,
1999; Yang et al., 2002). One possibility is that oxysterolsbinding, thus retaining SREBP in the ER in the presence
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